Clinical Trials Logo
  1. Home
  2. Wrinkle
  3. NCT06336044
  4. Details
NCT06336044 Clinical Trial

Pre-marketing Clinical Trial to Evaluate the Safety and Efficacy of the Filler of Hyaluronic Acid Recombinant Collagen

Wrinkle Clinical Trial

Official title:
Pre-marketing Clinical Trial to Evaluate the Safety and Efficacy of the Voluming Filler Based on Hyaluronic Acid Recombinant Collagen

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06336044
Other study ID # Taufiller/22
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date January 2025

Study information
Verified date March 2024
Source Taumedika s.r.l.
Contact Fabio Caviggioli, MD
Phone +393426179730
Email fabio.caviggioli@multimedica.it
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 20 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Description:

The patients chosen with facial laxity characteristics, at the first visit will be assessed and will receive the treatment (microinjections) in the cheekbone area, over the lips and in the marionette lines. After 4 weeks the first visit will assess the change of the tissutal structure with non invasive measurements.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 20
Est. completion date January 2025
Est. primary completion date November 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - all sexes - caucasic - 18 to 70 years - non smoker Exclusion Criteria: - Pregnancy - milking - smoker - alcohol or drugs abuse - change of BMI during the study - previous facial surgery, implants, permanent treatments - sensitivity to the product - dermatological difficult frame - health weakness - treated with anticoagulants, antihistaminics, corticosteroids, antidepressants and other drugs impacting on the results

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Karisma
Intradermal injection

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
Taumedika s.r.l. Nextrasearch S.r.l.s.

Outcome
Type Measure Description Time frame Safety issue
Primary Safety: no adverse events test the safety of the device evaluating any potential adverse event 16 weeks
Primary Efficacy: change of wrinkles and scars test the efficacy of the device measuring the skin surface using GAIS (Global Aesthetic Improvement Scale) scale 16 weeks
Primary Efficacy: change of wrinkles and scars test the efficacy of the device measuring the skin surface using Facial Volume Loss Scale (FVLS) 16 weeks
Primary Efficacy: change of wrinkles and scars test the efficacy of the device measuring the skin surface evaluating the face volume 16 weeks
Primary Efficacy: change of wrinkles and scars test the efficacy of the device measuring the skin surface with skin hydratation measurement 16 weeks
Secondary Duration of the efficacy measure the duration of the treatment 16 weeks
See also
  Status Clinical Trial Phase
Completed NCT05098912 - Comparing Polydioxanone Thread Embedding Acupuncture and Manual Acupuncture for Nasolabial Fold Reduction N/A
Completed NCT05271136 - A Clinical Study to Evaluate the Efficacy of an Anti-Aging Serum N/A
Completed NCT05096247 - Post Market Study To Collect Efficacy Data For The Treatment Of Wrinkles With A Radiofrequency Device N/A
Completed NCT05097157 - Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions N/A
Completed NCT04128046 - The Effect of Platelet-rich Fibrin Matrix on Skin Rejuvenation N/A
Active, not recruiting NCT04727099 - Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™ N/A
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Not yet recruiting NCT05524779 - BTL-785F Device for Non-invasive Reduction of Wrinkles and Overall Facial Improvement N/A
Completed NCT05514782 - A Clinical Study to Evaluate the Long-Term Efficacy and Tolerability of a Daily Anti-Aging Daily Serum N/A
Completed NCT06123572 - A Clinical Study to Assess the Safety and Effectiveness of Anti-Ageing and Skin Brightening Gel N/A
Completed NCT04911374 - An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream N/A
Recruiting NCT04989361 - Soluble Hyaluronic Acid Microneedle VS. Non-ablative Fractional Laser on Infraorbital Wrinkles. N/A
Recruiting NCT04540900 - A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions Phase 1
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Recruiting NCT06074276 - The Effects of Almond on Facial Skin Collagen and Wrinkles N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Active, not recruiting NCT06219278 - A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles N/A
Active, not recruiting NCT06192550 - Functional Usability and Feasibility Testing of the Profound Matrix™ System N/A
Completed NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® N/A
Completed NCT03729700 - The Effect of Almonds on Facial Aesthetics and Modulation of the Microbiome and Lipidome N/A